DeviceTalks News

CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details

CVRx Nadim Yared on COVID-19, diversity and equality; Hyalex CEO Mira Sahney shares startup details

In part 2 of an interview, we follow up with last week’s guest, CVRx CEO Nadim Yared, to catch up on how the medtech executive is managing during the pandemic.

Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society.

We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups. Hyalex was identified as a notable startup in this recent report in Medical Design and Outsourcing.

In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

 

CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.

CVRx CEO Nadim Yared on his path from engineer to CEO to industry leader.

This week, CVRX reported positive six-month trial results for its Barostim Neo, an FDA-approved treatment for heart failure.

The results follow years of close work between the agency and CVRx, one of the more ambitious startups in medtech. CVRx is targeting a huge clinical need with novel neuromodulation technology.

In this week’s DeviceTalks Weekly podcast, CEO Nadim Yared walks us through the negotiations the company went through with the FDA to get to this point.

 

Yared, the prior chairman of the industry group AdvaMed, also shares the story of his career, which started early on when he secured a job at GE even before graduating college.

In this talk, Yared speaks to several issues including:

  • The power of confidence and the dangers of overconfidence when building a career.
  • How he decided to take the job at CVRx (and why he didn’t initially want to talk about the job with a recruiter.)
  • What CVRx learned from other successes and failures in renal denervation.
  • Why the company is betting big on heart failure, but doesn’t have a Chief Medical Officer.
  • Whether or not his role as chairman at AdvaMed impacted his work at CVRx.
  • Can medtechs generate good returns after raising hundreds of millions in capital?

 

This conversation took place prior to the emergence of COVID-19, so DTW host Tom Salemi visited again with Yared more recently. We’ll play that interview in next week’s episode of DeviceTalks Weekly.

If you’re looking for more medtech discussions, register now for DeviceTalks Tuesday at devicetalks.com.

Subscribe to the podcast. Don’t miss an episode!

Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by start-ups Circadia Health and Perceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

We also unveil the 20 medical device companies you need to know.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function. Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, Sr. Program Manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Dohse partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare. On Tuesday, she’ll discuss.

  • How do we weigh “patient lifestyles” vs. “therapy/product” lifecycles”?
  • What impact will connected devices and apps have on patient outcomes?
  • How can data help improve and even transform the patient experience?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

Stryker’s Kevin Lobo, Dexcom’s Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal

Stryker’s Kevin Lobo, Dexcom’s Kevin Sayer talk diversity, COVID-19; also more on Medtronic deal

 

This podcast is sponsored by maxon.

This week’s DeviceTalks Weekly podcast episode talks with industry leaders about improving worker diversity and developing new ways to treat COVID-19 patients.

Kevin Lobo, chairman and CEO of Stryker, explains how his company – and the industry group AdvaMed – has been working to increase diversity of its workforce, particularly in senior and sales positions. Lobo is serving a two-year term as chairman of AdvaMed. In this interview, Lobo speaks specifically to how Stryker is tracking progress, where it has come up short, and how it’s working to help workers identify their own biases.

Lobo also says Stryker is poised to regain momentum after the pandemic.

Next, Kevin Sayer, executive chairman, CEO and president of Dexcom, says the company’s continuous glucose monitors are finding a home in hospitals as they help monitor the health of COVID-19 patients. Sayer says the company’s monitors have helped keep patients, especially diabetics, off ventilators and allowed them to get discharged more quickly. What’s next for Dexcom? “We think this is an important market for us, not just COVID-wise,” Sayer says.

Finally, Raj Denhoy, equity research analyst at Jefferies, breaks down private equity group Blackstone’s investment in Medtronic’s diabetes line. Why would the medtech giant take outside money? Is this something we’ll see more of in medtech?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 13 –  Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

DeviceTalks Weekly: Ep. 13 – Cala Health CEO Renee Ryan Brings Business Building Insights to Bioelectronic Medicine Startup

In this week’s episode of DeviceTalks Weekly, Tom Salemi, editorial director of DeviceTalks events and content, visits with Renee Ryan, the CEO of neuromodulation startup Cala Health.
Ryan came to Cala from the venerable medtech investor Johnson & Johnson Development Corp., where she made over 15 investments helping to create companies including Auris Surgical, Cala and digital surgery play Verb Surgical, J&J’s joint venture with Verily. “I really set my mind to was there a way we could create our own opportunities,” she said of her eight years as the corporate investor.
We ask Ryan about her move into medtech investing from investment banking as well as the “secret power” that helped her succeed as an investor and an executive.
We’ll also discuss the unique commercial strategy Cala is employing as it begins rolling out its Cala Trio, a bioelectronic device developed to treat essential tremor.

  • What role will tech companies play in medtech’s future?
  • Did Verb Surgical meet her expectations?
  • As CEO how do you manage investor syndicates with multiple corporate investors?
  • Can Cala secure reimbursement and create a new market for tremors?
  • What grade did she skip as a child?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DTW’s Commencement Speaker – Todd Brinton, MD, Edwards Lifesciences on building a career in medtech

DTW’s Commencement Speaker – Todd Brinton, MD, Edwards Lifesciences on building a career in medtech

In this week’s DeviceTalks Weekly podcast, we attempt to deliver heartfelt and hard won advice in a sort of commencement address by Todd Brinton, MD, Corporate Vice President, Advanced Technology and Chief Scientific Officer of Edwards Lifesciences.

Dr. Brinton sits down with host Tom Salemi to share his path into Medtech. Brinton shares great advice for anyone looking for a new career or opportunity in medtech.

*This interview took place in March

DeviceTalks Weekly: Ep. 11 –  Medtronic is buckling up and ready to buy

DeviceTalks Weekly: Ep. 11 – Medtronic is buckling up and ready to buy

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry.

In this week’s episode of DeviceTalks Weekly, we dip into Medtronic’s quarterly call to hear why company executives feel the medtech sector is already rebounding. The global giant also intends to start using its vast cash reserves to bolster its bottomline through M&A.

We’ll also talk with Jeff Champagne of MPR about medtech’s need for speed. He’ll be leading a discussion on this subject and more on the upcoming DeviceTalks Tuesdays.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 10 – How do venture investors make, manage investments going forward?

DeviceTalks Weekly: Ep. 10 – How do venture investors make, manage investments going forward?

In this week’s episode of DeviceTalks Weekly, we talk with venture capital investors about how they’re building and maintaining their medtech portfolios during this pandemic landscape.

Our guests this week are…

  • Justin Klein, MD, managing partner, Vensana Capital
  • Duke Rohlen, chairman, Ajax Health

Together, Klein and Rohlen have created, backed and sold medtech companies that have generated billions.

Klein, formerly of New Enterprise Associates, now co-manages his own venture firm, Vensana Capital. He previously served on the board of directors of Cartiva (acquired), ChromaCode, CV Ingenuity (acquired), EPIX Therapeutics (acquired), FIRE1, GPB Scientific, Intact Vascular, Metavention, Personal Genome Diagnostics, PhaseBio Pharmaceuticals (IPO), Relievant Medsystems, Senseonics (IPO), Topera (acquired), Ulthera (acquired), Vertiflex (acquired), Vesper Medical, and VytronUS (acquired).

Rohlen, who leads a holdings company backed by private equity giant KKR, previously served as chairman and CEO of EPIX, Co-founder, Chairman and CEO of Spirox, Inc (sold to Entellus Medical) and co-founder and CEO of CV Ingenuity. He was also president of Fox Hollow before it was acquired by EV3.

In this podcast we’ll learn how VCs are looking at investment opportunities in this market

  • Are they making new investments?
  • What impact is this having on valuation?
  • Do VCs give stronger consideration to new concerns like supply chain?
  • How are they managing burn rates in their existing portfolio companies?
  • When will they get clinical trials up and running?

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 9 – What’s the State of the Medtech Job Market?

DeviceTalks Weekly: Ep. 9 – What’s the State of the Medtech Job Market?

In this week’s episode of DeviceTalks Weekly, Tom Salemi speaks with two executive recruiters about what they see in the medtech market. Over the past month, we’ve seen several medtech companies – big and small – cutting jobs and reducing hours but what does this mean long-term.

In this podcast we’ll identify a few companies that are hiring, but we’ll talk in-depth with the recruiters about…

  • How bad is the current market?
  • What’s the likelihood for recovery?
  • What skills are in greater demand?
  • What can people do to strengthen their hand?

Guests are:

  • David L. Vied, global sector leader, Global Sector Leader, Medical Devices and Diagnostics, Korn Ferry
  • Giovanni Lauricella, vice president, medtech practice-lead, The Mullings Group

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep. 8: AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data

DeviceTalks Weekly: Ep. 8: AdvaMed‘s Scott Whitaker on pandemic readiness, Jon Norris of SVB shares Q1 venture capital investment data

In this week’s episode of DeviceTalks Weekly, Scott Whitaker, CEO of AdvaMed, shares concerns he had over how the federal government would work with the medtech industry during the pandemic crisis. Does he feel the medtech industry was treated fairly? How does he see the federal government and medtech industry working together in the future? He answers those questions and more.
In our second interview, Jonathan Norris, managing director of Silicon Valley Bank, shares first-quarter data for medtech venture investments. The results might surprise you.
Guests are:

  • Scott Whitaker, CEO, AdvaMed
  • Jonathan Norris, managing director, Silicon Valley bank

DeviceTalks Weekly: Ep. 7 – Edwards, Employment News, Update on Clinical Trials from Avania

DeviceTalks Weekly: Ep. 7 – Edwards, Employment News, Update on Clinical Trials from Avania

In this week’s episode of DeviceTalks Weekly, Tom Salemi and Chris Newmarker stare at each other through the Zoom lens while talking about the positive employment news from Baxter International and Conformis, the hopeful news from Edwards Lifesciences, and the cautionary tone from Medtronic. What can we expect from the rest of medtech?

In the first half of the podcast, we examine comments from Edwards’ Q1 call. The company is warning analysts about a rough second quarter but explains why the situation may improve in the second half of the year.
For a look at the state of clinical trials in medtech, we talk with Mark McIlduff, general manager, U.S., at the newly named CRO, Avania. McIlduff walks us through how clinical trials were shut down by the Covid-19 crisis and what it might take to get them started in the future.

DeviceTalks Weekly: Ep. 6 – Hear about the Coventor ventilator, Q1 earnings and MassDevice’s Medtech 100 Index

DeviceTalks Weekly: Ep. 6 – Hear about the Coventor ventilator, Q1 earnings and MassDevice’s Medtech 100 Index

In this week’s episode of DeviceTalks Weekly, Aaron Tucker of the Earl Bakken Medical Center shares the origin of the recently approved Coventor ventilator, which will be manufactured at-cost by Boston Scientific.

We’ll also hear comments Abbott CEO Robert Ford made during the company’s Q1 analyst call as the MassDevice team begins to dissect how the COVID-19 pandemic will impact medtech earnings.

Finally, Danielle Kirsh, senior editor at WTWH Media, will share the origins of our new MedTech 100 Index, a powerful new tool for measuring how large medtech companies are managing in this new economy.

Guests are:

  • Aaron Tucker, Lab Supervisor, University of Minnesota Earl E. Bakken Medical Device Center
  • Danielle Kirsh, Senior Editor, WTWH Media

DeviceTalks Weekly: Ep. 5 – How can startups move forward during a pandemic?

DeviceTalks Weekly: Ep. 5 – How can startups move forward during a pandemic?

Raising capital for startup is never easy. Try doing it during a pandemic.

In this week’s DeviceTalks Weekly, we’ll try to help entrepreneurs by talking with two guests who are committed to helping startups find the funding they need.

Paul Grand, founder and CEO of MedTech Innovator, explains how he’s working to keep startups connected to capital. His popular MedTech Innovator program is adapting to the times and creating new ways for startups to get in front of investors.

We’ll also talk with Shai Policker, CEO at MEDX Xcelerator, an incubator backed by Boston Scientific, Intellectual Ventures and others. Based in Israel, MEDX is moving forward and interested in investing capital in start-ups worldwide.

Both give advice to fund-raising entrepreneurs and offer some helpful resources.

Co-host Chris Newmarker, executive editor, life sciences, for WTWH Media, also reviews the latest in COVID-19 news on MassDevice and Medical Design and Outsourcing.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?

DeviceTalks Weekly: Ep.4 — What does Medtronic’s Puritan reveal mean for medtech?

What does Medtronic’s Puritan reveal mean for medtech?

Medtronic earned plaudits and praise for sharing the design specifications for its Puritan Bennett 560 (PB560) ventilators. But will the gesture actually lead to more ventilators being manufactured?

In this episode of DeviceTalks Weekly, we’ll talk with experts who will tell us what the plans do and do not say. We’ll also get some legal insights on what strings are attached to the open-source effort.

Guests are:

  • D. Brian Kacedon, partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
  • Lee Teschler, executive editor, WTWH Media
  • Scott Thielman, CTO, Product Creation Studio

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news

DeviceTalks Weekly Podcast: Deconstructing medtech’s alphabet soup – DPA, MDR, FDA are all in the news

In this week’s DeviceTalks Weekly, we’ll examine how governmental effort, both foreign and domestic, are hitting the medtech industry.

Our guests include Tracy Eberly, CEO of Fang Consulting, a regulatory advisory group. Eberly will update listeners on what pushing back the MDR deadline could mean for medtech companies and why some companies may be less than thrilled with the decision.

In our second conversation, Joy Sturm, procurement expert and partner at the DC office of Law Firm Hogan Lovells, walks us through the powers contained within the Defense Production Act (DPA) invoked last week by the Trump administration.

Sturm, who brings 20 years of governmental purchasing experience to the conversation, answer several key questions including:

  • What CAN and CAN’T the government do under the act?
  • Which federal agencies are responsible for executing the DPA?
  • Can companies secure capital to pay for DPA-supported efforts?
  • What player is missing on the field in the battle against COVID-19?

Also, Advamed is also looking for direction from the Federal government. You may be surprised by the potential source of leadership.

Finally, MassDevice honcho Chris Newmarker talks DYI ventilators. Check out Mass Device’s Sean Whooley’s feature here.  And what does the FDA say about these projects?

DeviceTalks Weekly: Medtech goes to war with COVID-19

DeviceTalks Weekly: Medtech goes to war with COVID-19

In this week’s DeviceTalks Weekly Podcast, we’ll talk about medtech’s essential role in the escalating war against COVID-19.

We’ll visit with Fluidda CEO Jan De Backer and Kevin Thornal, division president of diagnostic solutions at Hologic. The executives will explain how their imaging and diagnostic devices – which both received recent FDA approval –  will aid against the diagnosis and treatment of COVID-19. 

We’ll also discuss how these two medtech executives view the Trump Administration’s invoking of the Defense Production Act, a Korean-war era law that could have unseen impacts on medtech companies and their supply chain.

DeviceTalks Weekly is hosted by Tom Salemi, editorial director, DeviceTalks, and Chris Newmarker, executive editor, life sciences.

DeviceTalks Weekly: How is coronavirus affecting medtech?

DeviceTalks Weekly: How is coronavirus affecting medtech?

Welcome to the DeviceTalks Weekly podcast, a regular – and sometimes irregular – opportunity to visit with the editorial team at MassDevice and Medical Design & Outsourcing.

This week, Chris Newmarker, executive editor, life sciences, at WTWH Media, reviews our COVID-19 coverage with Tom Salemi, editorial director, DeviceTalks. Tom also chats with Jeffries analyst Raj Denhoy, who details how the medtech sector is faring in this unprecedented uncertainty.

While most medtech companies stand on strong financial footing, Denhoy issues a warning to investors that another correction may be coming once analysts start assessing the impact on earnings. Still, he says there are safe havens out there and identifies one in the podcast. Finally, Tom and Chris explore what impact social distancing may have on medtech in the short-term – sales and deals – and long-term – innovation.

Experts explore the state of M&A in medtech

Experts explore the state of M&A in medtech

At DeviceTalks West 2018, a panel of experts gathered to discuss the state of M&A in medtech and the forces driving startups to seek an exit. Read more >>

Prioritizing Innovation – How major players in medtech stay ahead of the curve

Prioritizing Innovation – How major players in medtech stay ahead of the curve

In the medtech industry, if you don’t innovate, you can’t compete. Read more >>

What should the Mann Foundation do next?

What should the Mann Foundation do next?

Dr. Robert Greenberg, the Mann Foundation’s new executive chairman, has ideas about where to take one of medtech’s top research and development outfits. He explained more at DeviceTalks West in December. Read more >>

Diabetes tech execs talk patient-centric design, device development & trust

Diabetes tech execs talk patient-centric design, device development & trust

John Timberlake has been commercializing diabetes drugs and devices for 25 years. Over the course of his career, one theme has always stood out: if you want people to use your product, it has to be made with the end-user in mind. Read more >>

Here’s how Intuitive Surgical is innovating to stay competitive

Here’s how Intuitive Surgical is innovating to stay competitive

Intuitive Surgical isn’t resting on its laurels when it comes to the surgical robotics field that it dominates. The Sunnyvale, Calif.­–based company is seeking to stay competitive through technologies including computer-controlled navigated robotic catheters, contrast agents to improve imaging during procedures, and intelligent surgical interfaces. Read more >>

How Reggie Groves reinvented Medtronic’s atrial fibrillation biz

How Reggie Groves reinvented Medtronic’s atrial fibrillation biz

Reva Medical CEO Reggie Groves got her start in the medical device industry at medtech titan Medtronic. In her upcoming keynote interview at DeviceTalks West, Groves will discuss how that experience has shaped her as a leader and an innovator. Here’s a preview. Read more >>

Alfred Mann Foundation chairman looks outward to extend founder’s legacy

Alfred Mann Foundation chairman looks outward to extend founder’s legacy

When medtech pioneer Alfred Mann died in February 2016, he left behind a rich legacy of pure innovation and patient impact spanning the breadth of healthcare, from cardiology to hearing impairment, blindness and diabetes that will improve the lives of patients for decades to come. Read more >>

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

Today Gary Guthart is best known as the CEO of Intuitive Surgical, the world’s leading medical robotics company. But robot-assisted surgery wasn’t Guthart’s first love, he told MassDevice.com ahead of his keynote appearance at this year’s DeviceTalks West event. Read more >>

Here’s the view from the top at Hologic

Here’s the view from the top at Hologic

Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Read more >>

DeviceTalks Boston: 5 medtech startups you need to know

DeviceTalks Boston: 5 medtech startups you need to know

Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Read more >>

DeviceTalks: Hologic CEO MacMillan on leading a turnaround and the importance of women’s health in medtech

DeviceTalks: Hologic CEO MacMillan on leading a turnaround and the importance of women’s health in medtech

Stephen MacMillan joined a struggling Hologic as CEO in December 2013, and within one day, he had already made his first major move in restructuring the company’s executive leadership team. Read more >>

7 medtech ideas out of Europe

7 medtech ideas out of Europe

Mobile and digital health ideas — and overall medtech innovation ideas — abound in Europe, with DeviceTalks Boston attendees getting just a sampling this morning from seven CRAASH Barcelona participants. Read more >>

When product development goes sideways (and how to fix it)

When product development goes sideways (and how to fix it)

We would all like for product development projects to go smoothly and predictably, but you know what they say about “the best-laid plans.” Robert Burns aside, when needed technologies do not integrate as easily as planned, hardware or software bugs crop up at the last minute (or worse, cause failures in the field), or project teams struggle to complete work on schedule, forward progress is stalled. Fixed costs stay the same but time to launch date deadlines are compressed. This is only one example of when things go sideways. Read more >>

How strong patent portfolios attract strategic investments and deals

How strong patent portfolios attract strategic investments and deals

The medical device industry has demonstrated strong and sustainable growth in recent years. Given the aging population, increasing incidence of chronic and lifestyle diseases, emergence of artificial intelligence (AI) and big data, and significant investments in R&D and M&A, the medtech sector appears to be in prime health. According to KPMG, the medical device industry’s global annual sales are forecast to rise more than 5% a year to reach nearly $800 billion by 2030. As the industry evolves, medtech companies are making strategic moves to stay ahead in their respective markets. Read more >>

Lessons learned: How Jeff Karp stays at the forefront of innovation

Lessons learned: How Jeff Karp stays at the forefront of innovation

Serial entrepreneur Jeff Karp has a philosophy for his laboratory: find important problems and get solutions to people quickly. Read more >>

The future of Abbott’s electrophysiology business

The future of Abbott’s electrophysiology business

At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Read more >>

How Intuitive Surgical’s robotic systems are changing surgery

How Intuitive Surgical’s robotic systems are changing surgery

Robots are making their way into operating rooms around the world, acting as extensions of the surgeon. Intuitive Surgical, a mainstay in the robotic-assisted surgery field, has positioned its technologies as helping surgeons boost their performance and offer minimally-invasive options to patients. Read more >>

How Bigfoot Biomedical’s CEO wants to boost diabetes management

How Bigfoot Biomedical’s CEO wants to boost diabetes management

Jeffrey Brewer faced the biggest challenge of his life when his 7-year-old son Sean received a diabetes diagnosis in 2002: Diabetes became the new focus for Brewer’s energy. Read more >>

Speakers you need to see at DeviceTalks Minnesota

Speakers you need to see at DeviceTalks Minnesota

A Google executive whose own heart problems spurred her to seek medtech innovation, a leader at Abbott who wants to drive healthcare value, the head of an upstart company seeking to transform diabetes care — those are but some of the speakers you will encounter at DeviceTalks Minnesota this June. Read more >>

All heart: A Google executive’s real-world experience with medtech

All heart: A Google executive’s real-world experience with medtech

After hearing the story of her 10 cardiac surgeries and seven pacemakers, you could be forgiven for thinking that Heidi Dohse has a weak heart. But the Google executive, endurance cyclist and, now, inspirational speaker she may have a stronger heart than most people on the planet. Read more >>

7 ways you can doom your medical device startup

7 ways you can doom your medical device startup

Randy Nelson has worked with medical device startups for more than a dozen years through his Evergreen Medical Technologies (St. Paul, Minn.), as well as the University of Minnesota’s Carlson School of Management. Read more >>

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

For this Abbott executive, solving problems isn’t enough: ‘We need to add value’

As payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told MassDevice.com why simply solving problems with new technology isn’t enough anymore, learn here. Read more >>

Stroke treatment: There’s a simple way to improve it in the U.S.

Stroke treatment: There’s a simple way to improve it in the U.S.

Technology is already available to greatly improve outcomes for people suffering from strokes, but the present healthcare system is standing in the way of people getting it, according to Stacey Pugh, VP and general manager of the neurovascular unit at Medtronic. Read more >>

DeviceTalks West: Here are the speakers you’ll see

DeviceTalks West: Here are the speakers you’ll see

Hundreds of medical device industry insiders are expected to descend on Orange County, Calif., this month for DeviceTalks West – a premier boutique networking and learning event. Read more >>

DeviceTalks: 3M’s Cindy Kent on leadership, growth and inclusion in medtech

DeviceTalks: 3M’s Cindy Kent on leadership, growth and inclusion in medtech

Cindy Kent is no stranger to medtech – she’s spent 20 years in healthcare, moving up the ranks and finding her way to president & GM for 3M’s infection prevention division. She spoke with MassDevice.com Publisher Brian Johnson at the DeviceTalks event in Minnesota this week about her skills as a leader, how she ended up as an ordained minister and the importance of inclusion and mentorship in the workplace. Read more >>